The EEF2 gene gives your cells instructions for a protein that helps ribosomes move step by step as they build other proteins. If this gene does not work properly, cells may struggle to make proteins efficiently, which can especially affect the brain and nervous system. Pathogenic variants in the EEF2 gene are linked to some forms of developmental delay, intellectual disability, seizures, and movement or balance problems.
What is a gene?
Genes are stretches of DNA that give your cells instructions for making molecules or directing processes in the body. Some genes hold the directions for producing proteins, the active parts of cells. Other genes are mainly involved in controlling when certain processes happen, where they take place, and how strongly they run. Taken together, genes affect how the body develops and works, and they can influence how you respond to food, stress, or medications. For a deeper look at this topic, you can find more in the LearnHub.
Overview
EEF2Gene function
What if the gene works
The EEF2 gene helps cells make proteins by moving the machinery that reads genetic instructions. This supports everyday cell growth, repair, and maintenance.
Risk
What if the gene does not work
Variants in the EEF2 gene can affect brain development or coordination. Milder changes are linked to adult-onset spinocerebellar ataxia, a condition affecting balance and speech, while more severe variants may cause earlier neurodevelopmental features such as developmental delay.
Treatment
What does that mean for your treatment
No treatment or management approach specifically tied to the EEF2 gene is currently established. Treatment is guided by a person’s symptoms rather than by the EEF2 gene change itself. The EEF2 gene is being studied in cancer and cell growth research as a possible biomarker, but not as a routine guide for drug choice.
Conditions associated with EEF2
Gene function
What if the gene works
Your cells are always making proteins to support muscles, nerves, skin, and many other tissues. The EEF2 gene helps one key step happen smoothly by keeping the cell's protein-making process moving forward. Understanding what the EEF2 gene does in the body helps show how cells handle everyday maintenance and growth.
The EEF2 gene helps the cell's protein-making machine move forward as a new protein is being assembled. This keeps the growing protein chain extending in the right order.
Its protein uses cellular energy to shift the ribosome (the cell's protein-making machine) ahead after each new building block is added. That movement allows the next instruction to be read so protein production can continue smoothly.
Because nearly all cells need fresh proteins, the EEF2 gene supports routine growth, renewal, and day to day tissue maintenance. This steady activity helps cells keep their normal work on track.
What is a variant?
A genetic variant is a small difference in the DNA sequence within a gene. These differences are common and help create normal human diversity, such as variation in appearance, metabolism, or how the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some situations, though, a variant can change a gene’s function more significantly and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Changes in the EEF2 gene can make the eEF2 protein less stable or less able to help cells extend new proteins, which can slow a key step in protein production. Some variants have a milder effect, while more disruptive variants can cause a larger drop in activity or in the amount of working protein. In people with EEF2-related neurologic conditions, stronger functional effects may be linked to earlier onset or more marked symptoms.
How variants are linked to conditions
Rare disease-causing variants in the EEF2 gene can cause spinocerebellar ataxia type 26, a hereditary condition that affects balance, coordination, and speech over time. When doctors discuss EEF2 gene variants linked to health conditions, spinocerebellar ataxia type 26 is the clearest and best established finding. A few other rare variants have also been reported in children with developmental delay, seizures, or other neurologic features, but those links are less firmly established and may vary from person to person.
A variant is not necessarily a diagnosis
Across the general population, genetic variants are both common and a normal part of human biology. Most have no direct impact on health and simply represent natural human diversity. For many genes, carrying a variant tied to a condition suggests a possible association, not a definite diagnosis, especially when more than one gene and environmental factors contribute. In some instances, however, a single well-characterized variant in a particular gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the EEF2 gene. Risk usually depends most on the exact gene change and the condition linked to it, so personal guidance from a doctor or genetic counselor can be helpful.
Inheritance of EEF2 variants
EEF2-related conditions that have a confirmed inheritance pattern are inherited in an autosomal dominant way. If you are looking into how EEF2 gene variants are inherited, this usually means a parent carrying a disease-causing variant has a 50% chance of passing it on to each child. Some people with an EEF2-related condition have a new, de novo variant, which means it was not inherited from either parent. Sons and daughters are affected with equal likelihood.
What does my EEF2 result mean for my family?
For EEF2, the best-established family pattern is dominant, which means a parent, sibling, or child may also carry the same gene change. In families with an EEF2-related condition, close relatives may want to learn whether they have the same result, especially if they have balance, walking, or coordination problems. The exact impact on relatives can vary from one family to another.
Genetic information
Genetic testing
How you find out about variants
Variants in the EEF2 gene are usually found through genetic testing for EEF2 variants, using a blood sample, saliva, or sometimes a cheek swab. A lab reads the DNA sequence and compares it with the usual pattern to see whether a variant is present.
When should I consider getting a genetic test?
Genetic testing for the EEF2 gene may be worth discussing if you or close relatives have a pattern of balance and coordination problems, tremor, or speech changes that suggest an inherited form of ataxia, a condition that affects movement control. Testing is most useful when these symptoms run in a family or start without a clear cause.
A genetic result is only one part of your health story
A genetic result can give useful insight, but how much it explains varies with the condition and the kind of variant involved. Over time, many factors, including lifestyle, environment, age, and medical history, also influence how the body functions. For some conditions, particularly those shaped by many genes, genetic information provides context rather than certainty and is most helpful when viewed together with other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, genetic results can also help put personal experiences in context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in genes can change how the body breaks down a drug, moves it through the body, or how strongly it acts on its target. This helps explain why the same treatment works well for one person, has less effect in another, or causes more side effects in someone who is more sensitive.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can affect a person’s response to medications. It focuses on gene-drug patterns to help explain why the same treatment may work differently from one person to another. For many medicines, genes can influence how strongly a drug works or how the body processes it. This information can support more informed and individualized treatment decisions. More on this topic is available in the LearnHub.
Drugs influenced by the EEF2 gene
When should I seek medical advice?
There is no broadly confirmed evidence that changes in this gene should guide medication choice or response at this time, so questions about side effects, new symptoms, or how medicines may affect you are best discussed with your doctor.
History
First studied as part of the machinery that helps cells build proteins, the EEF2 gene gained attention through research on a protein called elongation factor 2 in the 1960s and 1970s. Scientists learned that this factor was the key target of diphtheria toxin, which made it important in both basic biology and infectious disease research. Building on this early work, scientists uncovered more about the gene when human DNA methods improved and the EEF2 gene itself was identified and mapped. Later studies connected rare EEF2 gene variants with certain inherited nerve and movement conditions, which expanded its medical importance. This history made EEF2 part of a broader story about how gene research moved from cell biology to patient care.